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ABSTRACT: Cytochromes P450 (CYPs) catalyze various oxidative transformations in drug metabolism, xenobiotic degradation 
and natural product biosynthesis. Here we report biochemical, structural and theoretical studies of TxtC, an unusual bifunctional CYP 
involved in the biosynthesis of the EPA-approved herbicide thaxtomin A. TxtC was shown to hydroxylate two remote sites within 
the Phe residue of its diketopiperazine substrate thaxtomin D. The reactions follow a preferred order, with hydroxylation of the -
carbon preceding functionalization of the phenyl group. To illuminate the molecular basis for remote site functionalization, X-ray 
crystal structures of TxtC in complex with the substrate and monohydroxylated intermediate were determined. Electron density cor-
responding to a diatomic molecule (probably dioxygen) was sandwiched between the heme iron atom and Thr237 in the TxtC-inter-
mediate structure, providing insight into the mechanism for conversion of the ferrous-dioxygen complex into the reactive ferryl 
intermediate.  The substrate and monohydroxylated intermediate adopted similar conformations in the active site, with the -face of 
the phenyl group positioned over the heme iron atom. Docking simulations reproduced this observation and identified a second, 
energetically similar but conformationally-distinct binding mode in which the -hydrogen of the Phe residue is positioned over the 
heme prosthetic group. Molecular dynamics simulations confirmed that the -hydrogen is sufficiently close to the ferryl oxygen atom 
to be extracted by it and indicated that the two substrate conformations cannot readily interconvert in the active site. These results 
indicate that TxtC is able to hydroxylate two spatially remote sites by binding distinct conformations of the substrate and monohy-
droxylated intermediate. 
Introduction 
Cytochromes P450 (CYPs) are versatile monoxygenases that 
employ a heme prosthetic group ligated to a conserved active 
site Cys residue and an electron transfer protein partner to acti-
vate molecular oxygen.1 The resulting ferryl (FeIV=O) reactive 
intermediate effects a wide range of oxidative transformations. 
These enzymes frequently play key roles in the biosynthesis of 
microbial natural products, including the assembly of non-pro-
teinogenic amino acid precursors, and the catalysis of diverse 
on and post-assembly line tailoring reactions.2-6 A handful of 
CYPs, all of which tailor the products of polyketide synthase 
assembly lines, have been shown to be multifunctional7. These 
enzymes catalyze the sequential oxidation of two or three prox-
imal carbon centers and in most cases come from Actinobacte-
ria (Figure 1), although fungal examples are also known. Struc-
tural studies of two such enzymes have indicated that only small 
changes in the positioning of the substrate relative to the heme 
prosthetic group are required to achieve the successive oxida-
tion reactions, because the atoms undergoing functionalization 
are positioned adjacent to each other.8-10 
Several plant-pathogenic Actinobacteria, including Streptomy-
ces acidiscabies, Streptomyces turgidscabies and Streptomyces 
scabies, produce thaxtomins, a family of phytotoxic diketop-
iperazines that inhibit cellulose biosynthesis in expanding plant 
tissues.11 S. scabies causes common scab in potatoes and other 
economically important crops,12 and thaxtomin A 1 has been 
approved by the EPA for use as an herbicide (registration num-
ber: 84059-12), although it has yet to reach the market. Five 
genes within a mobile pathogenicity island are responsible for 
thaxtomin biosynthesis in S. scabies 87.22 (Figure 2).11 The txtA 
and txtB genes encode a dimodular nonribosomal peptide syn-
thetase (NRPS) that assembles thaxtomin D 2 from L-Phe, L-4-
nitrotryptophan and two units of S-adenosyl-L-methionine 
(SAM) (Figure 2).13 The txtE gene encodes an unusual CYP that 
catalyzes regiospecific nitration of L-Trp at the 4-position of the 
indole using O2 and NO, which is generated from L-Arg by the 
nitric oxide synthase encoded by txtD.3, 14 Gene deletion exper-
iments have implicated txtC, which is also predicted to encode 
a CYP, in the conversion of thaxtomin D 2 to thaxtomin A 1.15 
However, direct evidence for hydroxylation of both the Phe -
carbon and the phenyl group in thaxtomin D 2 by TxtC is lack-
ing. Moreover, catalysis of both these reactions by a single CYP 
could be considered somewhat remarkable, given that the re-
sulting hydroxyl groups are separated by almost 7 Å in the X-
ray crystal structure of thaxtomin A 1.16    
Figure 1: Structures of actinobacterial polyketides assembled 
by multifunctional CYPs. The oxygen atoms introduced by the 
CYP in each case are highlighted in red.  
 Here we report the overproduction in Escherichia coli and pu-
rification of TxtC, and show that it catalyzes sequential hydrox-
ylation of the Phe -carbon and the phenyl group in thaxtomin 
D 2. X-ray crystal structures of TxtC in complex with thaxtomin 
D 2 and thaxtomin B 3 (the monohydroxylated intermediate), 
combined with docking and molecular dynamics simulations, 
suggest that the enzyme catalyzes functionalization of these two 
spatially remote carbon centers by binding distinct conforma-
tional states of its two substrates. 
txtA txtB txtCtxtEtxtD
Figure 2: Organization of the mobile pathogenicity island in S. 
scabies 87.22 responsible for thaxtomin biosynthesis (biosyn-
thetic genes are shaded blue) and proposed pathway for assem-
bly of thaxtomin A 1 (Fd = ferredoxin, FdR = Fd reductase). 
 
Results and discussion 
TxtC from Streptomyces acidiscabies 84.104 has previously 
been overproduced in E. coli, but UV-Vis spectroscopic analy-
sis of the purified protein indicated that it exists in the catalyti-
cally inactive P420 form.15 We cloned txtC from S. scabies 
87.22 and overexpressed it in E. coli as an N-terminal His6-fu-
sion. The resulting protein was soluble and was readily purified 
from cell lysate using Ni-NTA chromatography (Figure S1). 
The identity of the purified protein was confirmed by peptide 
mass fingerprinting and gel filtration chromatography indicated 
that it is monomeric (Figure S2). Absorbance maxima at 419 
and 450 nm were observed for the ferric and ferrous-CO forms 
of the protein, respectively, confirming that this CYP is pro-
duced in a catalytically active form (Figure S3). 
A mutant of S. acidiscabies 84.104 in which txtC has been dis-
rupted accumulates thaxtomin D 2, suggesting that this metab-
olite could be a substrate for TxtC.15 To test this hypothesis, we 
incubated purified recombinant TxtC with thaxtomin D 2, iso-
lated from the txtC mutant, NADPH, and spinach ferre-
doxin/ferredoxin reductase (required to transfer electrons form 
NADPH to the heme prosthetic group of CYPs). LC-MS anal-
ysis of the reaction mixture identified two major products, giv-
ing rise to ions with m/z values 16 and 32 Da higher than the 
substrate. Semi-preparative HPLC purification of these prod-
ucts from a scaled-up reaction and ESI-Q-TOF-MS analysis 
showed that the molecular formula of the higher molecular 
weight compound corresponds to that for thaxtomin A 1, 
whereas the lower molecular weight compound has the same 
molecular formula as thaxtomin B 3 (Figure S4). 1H NMR spec-
troscopic comparisons of the purified products with authentic 
standards of thaxtomins A and B isolated from S. acidiscabies 
84.104 confirmed these structural assignments (see supporting 
information). In addition to thaxtomin A 1, small amounts of 
two additional products with molecular weights 32 Da higher 
than the substrate were observed in the TxtC-catalyzed reaction. 
These compounds could not be purified in sufficient quantities 
to permit 1H NMR spectroscopic analysis. However, ESI-Q-
TOF-MS showed that they have the same molecular formulae 
as thaxtomin A 1 (see supporting information). These are likely 
isomers of thaxtomin A 1, in which the aromatic hydroxyl 
susbtituent is situated ortho or para to the methylene group, be-
cause such compounds are known to be biosynthesized in small 
amounts by thaxtomin-producing Streptomyces species. To 
substantiate this hypothesis, we purified an authentic standard 
of the o-isomer from S. acidiscabies 84.104, confirmed its iden-
tity by HRMS and 1H NMR spectroscopy, and showed that its 
retention time is identical to one of the minor dihydroxylated 
products of the enzymatic reaction (Figure S4). By a process of 
elimination, we assigned the other dihydroxylated product of 
the enzymatic reaction as the p-isomer. All four hydroxylated 
products were absent from control reactions in which the en-
zyme was inactivated by boiling, or from which the ferredoxin, 
ferredoxin reductase or NADPH were omitted (Figure S5). 
To investigate whether the TxtC-catalyzed hydroxylation reac-
tions follow a defined order, the disappearance of the substrate 
and the formation of mono- and dihydroxylated products was 
monitored over a 60 minute period (Figure 3). Within 5 
minutes, most of the substrate is consumed and thaxtomin B 3 
(along with a small amount of another monohydroxylated spe-
cies), thaxtomin A 1 and its o-isomer are formed. Over the next 
55 minutes, the amount of thaxtomin B 3 in the mixture steadily 
decreases and a concomitant increase in the quantities of thax-
tomin A 1 and its o/p-isomers is observed. These data imply that 
thaxtomin B 3 is the main intermediate in the TxtC-catalyzed 
 
Figure 3: Extracted ion chromatograms (EICs) from LC-MS 
analyses of TxtC-catalyzed hydroxylation of thaxtomin D 2 
showing that thaxtomin B 3 is an intermediate in its conversion 
to thaxtomin A 1. Top: EIC at m/z = 429 corresponding to 
[M+Na]+ for 2. Bottom: EIC at m/z = 445 and 461 correspond-
ing to [M+Na]+ for 1 and 3, respectively. The p- and o-isomers 
of 1 have retention times of ~10 and ~14 minutes, respectively. 
The compound with a retention time of ~12 minutes that forms 
transiently in small quantities during the course of the reaction 
has an m/z corresponding to an alternative monohydroxylated 
intermediate. 
   
Figure 4: Overall structure of the TxtC-thaxtomin D 2 complex 
highlighting the location of the heme prosthetic group (in 
green). The -helix and -sheet secondary structure elements 
are labeled according to standard CYP nomenclature.   
dihydroxylation of thaxtomin D 2. Incubation of thaxtomin B 3 
with TxtC, NADPH and spinach ferredoxin/ferrodoxin reduc-
tase resulted in the formation of thaxtomin A 1 as well as small 
quantities of its o/p-isomers, consistent with this hypothesis 
(Figure S4). 
Taken together our data unambiguously show that TxtC cata-
lyzes the final two steps in thaxtomin A 1 biosynthesis. They 
further suggest that these reactions occur in a preferred order, 
with hydroxylation of the Phe -carbon to give thaxtomin B 3 
occurring first, followed by functionalization of the phenyl 
group to give thaxtomin A 1, along with small quantities of its 
o and p-isomers. The fact that thaxtomin B 3, but no isomers in 
which the aromatic ring of the Phe residue is hydroxylated in-
stead of its -carbon are produced by thaxtomin-producing 
Streptomyces species further supports this conclusion. 
To develop an understanding of a how a single CYP is able to 
catalyze the successive hydroxylation of two spatially remote 
sites in a single molecule, TxtC was co-crystallized with its sub-
strate thaxtomin D 2 and the monohydroxylated intermediate 
thaxtomin B 3. The X-ray structures of these complexes were 
solved to 2.8 and 1.7 Å, respectively, by molecular replacement 
using MoxA from Nonomuraea recticatnina (PDB ID: 2Z36) 
as a template. Attempts to crystallize TxtC in the absence of 
substrate were unsuccessful, suggesting that the unliganded en-
zyme has a high degree of conformational flexibility. The over-
all structure of TxtC is very similar to that of other well-charac-
terized bacterial CYPs, such as P450cam (Figure 4).17 Both 
complexes were found to adopt an essentially identical closed 
conformation in which the substrates are sequestered from sol-
vent.  
In the structure of the TxtC-thaxtomin B complex, the 4-nitroin-
dole moiety of the substrate is embedded in a pocket lined by 
the side chains of predominantly hydrophobic residues (Leu74, 
Pro82, Val84, Phe182, Leu228, Met229 and Val232). On one 
side of this pocket, the carboxylate side chain of Glu69 forms a 
hydrogen bond with the N-H group of the indole (Figure 5A). 
Two further polar contacts between the substrate and the en-
zyme are mediated by water molecules. One of these forms hy-
drogen bonds with the side chain of Thr385, and the carbonyl 
group of the Phe residue in the substrate (Figure 5A). The other 
sits in close proximity to the carbonyl group of 4-nitrotrypto-
phan and one of the carboxylate groups of the active site heme 
(Figure 5A). Together these two water molecules anchor the 
diketopiperazine of thaxtomin B 3 in the active site, positioning 
the -face of the phenyl group in this monohydroxylated inter-
mediate over the heme prosthetic group (Figures 5A and S10). 
Electron density corresponding to a diatomic molecule was also 
found in close proximity to the heme iron atom with 100% oc-
cupancy (Figure 5A). This is likely dioxygen, which binds to 
the active site as a result of heme photoreduction during X-ray 
data collection, as reported previously for P450cam.18, 19 The 
distal end of this diatomic molecule (relative to the heme) hy-
drogen bonds to the side chain of Thr237, a highly conserved 
residue in CYPs that has been shown to be important for catal-
ysis.20, 21 A further water molecule sits within H-bonding dis-
tance of the Thr237 hydroxyl group, the distal end of the dia-
tomic molecule, and the water molecule that interacts with the 
Thr385 side chain (Figure 5A). 
The phenyl group of the substrate is positioned close to the 
proximal end of the heme-associated diatomic molecule in the 
TxtC-thaxtomin B 3 structure (Figure 5A). To investigate 
whether this binding mode permits hydroxylation of the phenyl 
group, we replaced the heme and its associated diatomic mole-
cule with compound I (heme oxyferryl complex) and carried out 
molecular dynamics (MD) simulations. The results of these 
simulations show that all five unsubstituted carbon atoms of the 
phenyl group are able to approach the ferryl oxygen to within 
~3.2 Å (Table 1), explaining why a mixture of o-, m- and p-
hydroxylated products is formed. The average and minimum 
distances of the unsubstituted carbon atoms from the ferryl ox-
ygen are smallest for the o-positions and largest for the p-posi-
tions (Table 1), although the differences are small and may not 
be relevant to the observed preference for m-hydroxylation. 
Nevertheless, it is possible that thaxtomin A 1 results only par-
tially from direct attack of the ferryl oxygen at the m-position 
(Figure 6). The intermediate resulting from attack of the ferryl 
oxygen at the o-position could undergo 1,3-elimination to form 
an arene oxide that rearranges via an “NIH shift” to form the m-
product (Figure 6). While the involvement of arene oxides in 
CYP-catalyzed aromatic hydroxylation reactions has been 
questioned on theoretical grounds,22 such a species has recently 
been implicated as an intermediate in the P450cam-catalysed 
oxidation of t-butyl-benzene.23 
  
Figure 5: (A) Active site in the TxtC-thaxtomin B 3 complex (PDB ID: 6F0C), highlighting key hydrogen bonding interactions 
between the substrate, protein and active site water molecules as dashed lines (top) and showing the electron density for the substrate, 
heme prosthetic group, diatomic molecule and three ordered water molecules (bottom). (B) Active site in the TxtC-thaxtomin D (2) 
complex (PDB ID: 6F0B) highlighting hydrogen bonds as dashed lines (top) and showing the electron density for the substrate, heme 
prosthetic group, and single ordered water molecule (bottom). Both 2F0-Fc electron density maps were contoured at 1 with the bound 
ligand atoms omitted from the density calculations.
Table 1: Minimum, maximum and average distances (Å) be-
tween the ferryl oxygen and the unsubstituted carbon atoms of 
the thaxtomin B 3 phenyl group observed in MD simulations. 
position minimum maximum average 
o/o' 2.81/2.83 4.58/4.91 3.61/3.75 
m/m' 3.19/3.13 5.35/5.95 4.28/4.64 
p 3.23 5.94 4.67 
 
The structure of the TxtC-thaxtomin B complex also suggests a 
mechanism for the transfer of protons from bulk solvent to the 
ferrous dioxygen complex via Asp236, which forms an inter-
face between the active site and a water filled exterior pocket 
(Figure 7). Two water molecules connect the distal end of the 
heme-associated diatomic molecule to the carboxylate side 
chain of Asp236 (Figure 5A) and are thus proposed to function 
as a proton relay (Figure 7). A similar mechanism, in which the 
corresponding aspartate residue (Asp251) and a single active 
site water molecule participate in proton delivery during the rate 
limiting step of O-O bond cleavage, has been proposed for 
P450cam.24 Consistent with this hypothesis, a D251N mutant 
was reported to be much less active than the wild type enzyme.24 
More recently, the binding of the electron donor putidaredoxin 
to P450cam has been shown to break a salt bridge between 
Lys178/Arg186 and Asp251, allowing the side chain of the lat-
ter to pick up a proton from the bulk solvent and deliver it to the 
active site.25, 26 This indicates that reduction of the ferrous-diox-
ygen intermediate and protonation of the resulting ferric perox-
ide are tightly coupled. TxtC contains an analogous salt bridge  
  
Figure 6: Possible mechanisms for TxtC-catalyzed conversion 
of thaxtomin B 3 to thaxtomin A 1. 
between Arg380 and Asp236, suggesting that it may employ a 
similar mechanism. 
Surprisingly, the substrate in the TxtC-thaxtomin D structure is 
bound in a very similar conformation to the monohydroxylated 
intermediate in the TxtC-thaxtomin B structure (Figures 5B and 
S10). In this conformation, the -hydrogen atom of the Phe res-
idue points away from the heme and appears to be too far away 
from the iron center to be extracted by the ferryl intermediate. 
Indeed, we could find no frames in MD simulations of this 
structure in which this hydrogen atom adopts a near attack con-
formation (a distance of >3.5 Å between the hydrogen atom and 
the ferryl oxygen and a C-H-O bond angle of 180 ± 45º; see 
Table S9).27 Moreover, no electron density corresponding to ei-
ther the diatomic molecule, or the two water molecules that con-
nect its distal end to Asp236 and Thr385 is observed in the 
TxtC-thaxtomin D structure (Figure 5B). As a consequence, the 
distance between the substrate and the I-helix (containing 
Asp236 and Thr237) decreases relative to the TxtC-thaxtomin 
B structure (Figure S11). In contrast, the water molecule sand-
wiched between the 4-nitrotryptophan carbonyl and heme car-
boxylate groups adopts a very similar position in both struc-
tures. The substrate binding mode observed in the TxtC-thax-
tomin D structure thus appears to disfavor formation of a fer-
rous-dioxygen complex, and the substrate must bind in a differ-
ent conformation to permit Phe -carbon hydroxylation. 
To investigate whether thaxtomin D 2 can bind to TxtC in dif-
ferent conformational states, docking simulations were con-
ducted using SwissDock.28 The results of these simulations pre-
dict that the active site of the enzyme can accommodate three 
distinct conformational states of thaxtomin D, which have pre-
dicted Gibbs free energies of binding within 0.2 kcal of each 
other (Figure S12). In all three of these states, the 4-nitroindole 
moiety is bound in the same position as that observed in the 
TxtC-thaxtomin D structure. Moreover, in one of the states the 
phenyl group of the substrate is positioned above the heme iron 
atom, accurately recapitulating the experimentally-observed 
substrate binding orientation in the TxtC-thaxtomin D structure 
(Figure S12). In another state, arising from rotation about the β-
γ bond of the 4-nitrotryptophan residue, the diketopiperazine is 
flipped such that the phenyl group is pointing towards the roof 
of the active site (Figures 8 and S12). This positions the -hy-
drogen atom of the Phe residue in close proximity to the heme 
iron atom and it was found to adopt a near attack conformation 
in 6% of the frames in MD simulations (Figures 8 and Table 
S9). No interconversion between the different substrate binding 
orientations was observed in the MD simulations. Close exam-
ination of the substrate binding site in TxtC indicates that a ste-
ric clash between the side chain of the Phe residue in the sub-
strate and the heme / residues 231-236 in the I helix prevents 
this. The switch in conformation of the monohydroxylated in-
termediate that enables hydroxylation of its phenyl group thus 
appears to require release from the active site of TxtC.  
 
Conclusion 
Our work demonstrates that TxtC is an unusual CYP capable of 
oxidizing two spatially remote sites in thaxtomin D 2. These 
hydroxylation reactions proceed in a preferred order with func-
tionalization of the Phe -carbon preceding oxidation of the 
phenyl group. X-ray crystallographic analysis of TxtC with the 
mono-hydroxylated intermediate thaxtomin B 3 bound in its ac-
tive site positions the -face of the phenyl group in this substrate 
over the iron atom of the heme prosthetic group, such that hy-
droxylation can occur. MD simulations of the TxtC-compound 
I-thaxtomin B complex confirmed that all five of the unsubsti-
tuted carbon atoms in the phenyl group are able to approach the 
ferryl oxygen atom sufficiently close to react. It appears that the 
predominant m-substituted product of the aromatic hydroxyla-
tion reaction may be formed by a combination of direct attack 
of the ferryl oxygen at the m-position and attack at the o-posi-
tion, followed by rearrangement to the m-product via an arene 
oxide intermediate. The TxtC-thaxtomin B structure also re-
vealed that a network of hydrogen bonds connects a heme iron-
bound diatomic molecule (probably dioxygen), via a pair of ac-
tive site water molecules, to a conserved aspartate residue, 
which is proposed to shuttle protons from the bulk solvent into 
the active site. This enables protonation of the ferric-peroxide 
intermediate leading to formation of the reactive ferryl species. 
Surprisingly, in the X-ray crystal structure of the TxtC-thax-
tomin D complex thaxtomin D 2 was bound in the same orien-
tation as thaxtomin B 3. MD simulations confirmed that the -
H of the Phe residue cannot be extracted by the ferryl
Figure 7. Proposed mechanism for transfer of protons from bulk solvent to the ferric peroxide intermediate in TxtC, via two active 
site water molecules and Asp236. The grey arrows indicate that a 180° rotation of the C-C bond in Asp236 is required to deliver the 
protons picked up from the bulk solvent into the active site. The juxtaposition of Asp236 and Arg380 between the substrate binding 
pocket and a water-filled exterior pocket is illustrated on the left. 
  
Figure 8: Example of a near attack conformation observed in 
MD simulations of TxtC containing the compound I complex 
and thaxtomin D 2 bound in the “flipped” orientation with the 
phenyl group pointing towards the roof of the active site. This 
positions the -hydrogen atom of the Phe residue sufficiently 
close to the ferryl oxygen to be extracted by it.  
 
intermediate when thaxtomin D is bound in this orientation. 
Docking simulations recapitulated this binding mode, but also 
revealed an energetically similar yet conformationally-distinct 
substrate binding orientation that places the Phe -hydrogen 
atom close to heme iron atom. MD simulations confirmed that 
this hydrogen atom can get close enough to the ferryl oxygen to 
be abstracted by it, when the substrate is bound in this orienta-
tion. Overall, our data indicate that the main reaction path of 
TxtC involves hydroxylation of first the Phe -carbon and then 
the phenyl group of thaxtomin D 2 by binding distinct confor-
mational states of the substrate and mono-hydroxylated inter-
mediate, contributing new insights into the mechanisms em-
ployed by multifunctional CYPs for the functionalization of 
spatially remote carbon atoms. 
Supporting Information: Experimental procedures, SDS-PAGE 
analysis of His6-TxtC expression and purification, the results of the 
enzyme activity assays, spectroscopic characterization data, and 
details of the docking and MD simulations are included in the sup-
porting information. This material is available free of charge via 
the Internet at http://pubs.acs.org. The coordinates of the TxtC-
thaxtomin D complex (Accession No. 6F0B) and the TxtC-thax-
tomin B complex (Accession No. 6F0C) have been deposited in the 
Protein Data Bank. 
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